China Regenerative Medicine International - Obagi Medical Products
China Regenerative Medicine International acquires Obagi Medical Products
Announced: July 17, 2017
Type: Acquisition
Disposition: Subsidiary
Terms: Cash
Status: Complete
Amount: $ 190,000,000